Dr. Reddy's Laboratories Ltd.
7-1-27 Greenlands
Ameerpet
Hyderabad,
500016
India - Map
Phone: 91 40 2373 1946
Fax: 91 40 2373 1955
Web Site: http://www.drreddys.com
| Dr. Reddys Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. The company focuses on formulations, active pharmaceutical ingredients and intermediates, generic drugs, critical care products, biotechnology products, custom pharmaceutical services, and drug discovery. It conducts research in the areas of cancer, diabetes, metabolic disorders, cardiovascular diseases, inflammation, and bacterial infection. In addition, the company involves in contract manufacturing of generic prescription and over-the-counter products for branded and generic companies in the United States. Further, Dr. Reddys offers central nervous system, pain management, gastrointestinal, respiratory, anti-infective, urology, womens health, spasticity, and alimentary tract related generics finished dosages. It markets its products in India, Russia, the United States, United Kingdom, Germany, South Africa, Brazil, China, Kazakhstan, Uzbekistan, Ukraine, Belarus, Vietnam, Romania, Venezuela, and Myanmar. The company has a co-development and commercialization agreement with Denmark based Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec International for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease; and an agreement with 7TM Pharma for the drug discovery collaboration on selected drug targets. Dr. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. K. Anji Reddy Ph.D., 69
Co-Founder, Exec. Chairman and Member of Scientific Advisory Board |
$
103.00K | N/A | Mr. G. V. Prasad B. Sc.(Chem Eng.), M.S. (Indl. Admn.), 48
Exec. Vice Chairman, Chief Exec. Officer, Member of The Management Council, Chairman of Investment Committee, Member of Management Committee, Member of Shareholders Grievance Committee and Member of Strategy Committee |
$
82.00K | N/A | Mr. Vishar Subramanian Vasudevan B.Com., ACA, 58
Pres, Member of the Management Council, Pres of Eurpoean Generics Bus. and Head of Europe Generics |
N/A
| N/A | Mr. Umang Vohra , 37
Chief Financial Officer and VP |
$
0 | N/A | Mr. Jaspal Singh Bajwa B . S c . , M.B.A., 57
Member of the Management Council and Pres of Branded Formulations Strategic Bus. Unit |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.06% Nasdaq 
Profile
